Real-World Evidence of EGFR Targeted Therapy in NSCLC– A Brief Report of Decade Long Single Center Experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-World Evidence of EGFR Targeted Therapy in NSCLC– A Brief Report of Decade Long Single Center Experience

Published:2023-11 Issue:11 Volume:4 Page:100566
ISSN:2666-3643
Container-title:JTO Clinical and Research Reports
language:en
Short-container-title:JTO Clinical and Research Reports

Author:

Chougule Anuradha,Chandrani Pratik,Noronha Vanita,Pange Priyanka,Kale Shrutikaa,Nikam Ankita,Nambiar Kavya,Marchande Dipika,Durve Arpana,Gupta Vinod,Jagtap Vinita,Tiwrekar Priyanka,Menon Nandini,Joshi Amit,Kaushal Rajeev,Pai Trupti,Patil Vijay Maruti,Dutt Amit,Banavali Shripad Dinanath,Prabhash Kumar

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference19 articles.

1. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

2. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

3. EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib;Pao;Proc Natl Acad Sci U S A,2004

4. Overview of current systemic management of EGFR-mutant NSCLC;Hsu;Ann Oncol,2018

5. Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity;Chougule;PLoS One,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Landscape of Clinically Relevant Genomic Alterations in the Indian Non-Small Cell Lung Cancer Patients;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP